The HLA system in hematopoietic stem cell transplantation - Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation - page 34

[37] Schipper RF, D'Amaro J, Oudshoorn M. The probability of finding a suitable related
donor for bone marrow transplantation in extended families. Blood 1996;87:800.
[38] Tiercy JM, Bujan-Lose M, Chapuis B, Gratwohl A, Gmur J, Seger R, et al. Bone marrow
transplantation with unrelated donors: what is the probability of identifying an HLA-
A/B/Cw/DRB1/B3/B5/DQB1-matched donor?. Bone Marrow Transplant 2000;26:437-41.
[39] Petersdorf EW, Gooley TA, Anasetti C, Martin PJ, Smith AG, Mickelson EM, et al.
Optimizing outcome after unrelated marrow transplantation by comprehensive match-
ing of HLA class I and II alleles in the donor and recipient. Blood 1998;92:3515-20.
[40] Sasazuki T, Juji T, Morishima Y, Kinukawa N, Kashiwabara H, Inoko H, et al. Effect of
matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic
stem cells from an unrelated donor. N Engl J Med 1998;339:1177-85.
[41] Ho VT, Kim HT, Liney D, Milford E, Gribben J, Culter C, et al. HLA-C mismatch is
associated with inferior survival after unrelated donor non-myeloablative hematopoi-
etic stem cell transplantation. Bone Marrow Transplant 2006;37:845.
[42] Flomenberg N, Baxter-Lowe LA, Confer D, Fernandez-Vina M, Filipovich A, Horowitz M,
et al. Impact of HLA class I and class II high resolution matching on outcomes of un-
related donor bone marrow transplantation: HLA-C mismatching is associated with a
strong adverse effect on transplant outcome. Blood 2004;104:1923-30.
[43] Morishima Y, Sasazuki T, Inoko H, Juji T, Akaza T, Yamamoto K, et al. The clinical
significance of human leukocyte antigen (HLA) allele compatibility in patients receiv-
ing a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched
unrelated donors. Blood 2002;99:4200-6.
[44] Lee SJ, Klein J, Haagenson M, Baxter-Lowe LA, Confer DL, Eapen M, et al. High-
resolution donor-recipient HLA matching contributes to the success of unrelated
donor marrow transplantation. Blood 2007;110(13):4576-83.
[45] Petersdorf EW, Anasetti C, Martin PJ, Gooley T, Radich J, Malkki M, et al. Limits of HLA
mismatching in unrelated hematopoietic cell transplantation. Blood 2004;104:2976-80.
[46] Chalandon Y, Tiercy JM, Schanz U, Gungor T, Seger R, Halter J, et al. Nicoloso de Faveri
G, Roosnek E, Passweg JR, Wiss Transplant Working Group for Blood and Marrow
Transplantation (STABMT), Swiss National Donor Registry. Impact of high-resolution
matching in allogeneic unrelated donor stem cell transplantation in Switzerland. Bone
Marrow Transplant 2006;37:909.
[47] Petersdorf EW, Kollman C, Hurley CK, Dupont B, Nademanee A, Begovich AB, et al. Effect
of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell
transplantation for chronic myeloid leukemia: The US National Marrow Donor Program
experience. Blood 2001;98:2922.
[48] Oudshoorn M, Cornelissen JJ, Fibbe WE, de Graeff-Meeder ER, Lie JL, Schreuder GM, et al.
Problems and possible solutions in finding an unrelated bone marrow donor. Results of
consecutive searches for 240 Dutch patients. Bone Marrow Transplant 1997;20:1011-7.
[49] Heemskerk MB, van Walraven SM, Cornelissen JJ, Barge RM, Bredius RG, Rm Egeler,
et al. How to improve the search for an unrelated haematopoietic stem cell donor.
Faster is better than more! Bone Marrow Transplant 2005;35:645-52.
[50] National Institutes of Health. NIH lymphocyte microcytotoxicity technique.
In: Anonymous NIAID Manual of Tissue Typing Techniques. Atlanta, GA: Department
of Health, Education, Welfare; 1979, NIH publication 80.
[51] Keever CA, Leong N, Cunningham I, Copelan EA, Avalos BR, Klein J, et al. HLA-B44-
directed cytotoxic T cells associated with acute graft-versus-host disease following
unrelated bone marrow transplantation. Bone Marrow Transplant 1994;14:137-45.
[52] Petersdorf EW, Hansen JA, Martin PJ, Woolfrey A, Malkki M, Gooley T, et al. Major-his-
tocompatibility-complex class I alleles and antigens in hematopoietic-cell transplanta-
tion. N Engl J Med 2001;345:1794-800.
[53] Woolfrey A, Klein JP, Haagenson M, Spellman S, Petersdorf E, Oudshoorn M, et al.
HLA-C antigen mismatch is associated with worse outcome in unrelated donor periph-
eral blood stem cell transplantation. Biol Blood Marrow Transplant 2011;17:885-92.
[54] Nagler A, Brautbar C, Slavin S, Bishara A. Bone marrow transplantation using unrelated
and family related donors: the impact of HLA-C disparity. Bone Marrow Transplant
1996;18:891-7.
[55] Petersdorf EW, Longton GM, Anasetti C, Mickelson EM, Smith AG, Martin PJ, et al. Defi-
nition of HLA-DQ as a transplantation antigen. Pro Natl Acad Sci USA. 1996;93:15358-63.
[56] Gajewski J, Gjertson D, Cecka M, Tonai R, Przepirka D, Hunt L, et al. The impact of T-
cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA sero-
logically identical unrelated donor bone marrow transplantation. Biol Blood Marrow
Transplant 1997;3:76-82.
[57] Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D, et al. Analy-
sis of risk factors for the development of GVHD after T-cell-depleted allogeneic BMT:
effect of HLA disparity, ABO incompatibility, and method of T-cell depletion. Biol Blood
Marrow Transplant 2001;7:620-30.

35